High Wire Networks, Inc. (OTCQB: HWNI), a global provider of managed cybersecurity services, today announced that its board of directors has determined ...

Company continues to progress both REYOBIQ radiotherapeutic clinical trials and CNSide® CSF assay platform launch readiness HOUSTON, May 30, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: ...

Stocks soared in May, boosted by easing trade tensions, solid corporate earnings and signs of economic resilience. Trade and ...